
|Articles|October 15, 2006
Study of PE drug shows efficacy over placebo
Minneapolis-For men suffering from the most common sexual dysfunction, premature ejaculation, an investigational drug therapy may offer improved control over ejaculation and sexual satisfaction with a relatively low incidence of side effects.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves Titan Prime Inflatable Penile Prosthesis
2
Clint Bahler, MD, reflects on precision medicine and focal therapy highlights at AUA 2026
3
RAD-IO: Durvalumab plus chemoradiotherapy is feasible in MIBC
4
Phase 1 AcTION trial establishes RP2D for 225Ac-PSMA-617
5











